Dyadic International Inc (DYAI) stock
Close on Nov 11, 2026Market cap $14.14MP/E –Yield –
Dyadic International Inc saw revenue fall 8.0% to $3.80M over the twelve months to Jun 30, 2026. At the latest close the market valued the company at $14.14M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $14.14M
- P/E ratio
- –
- Price to sales
- 3.72
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $3.80M
- Net income
- -$7.62M
- EPS, diluted
- -$0.23
- Book value per share
- -$0.07
- Diluted shares
- 36M
Trading
- Next earnings
- Nov 11, 2026 (estimated, after the close)
- Previous close
- $0.37
- Open
- $0.38
- Day's range
- $0.37 – $0.39
- Volume
- 45,245
- Average volume (20 days)
- 97,602
- Beta (5 years)
- 1.20
- 52-week range
- $0.33 – $1.60
- RSI (14 days)
- 47.1
- Volatility (1 year)
- 84.2%
- Relative volume
- 0.25×
- WACC
- 10.9%
Market cap history
Month-end market cap since 2018, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | DYAI | S&P 500 | Difference | DYAI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -12.6% | -2.4% | −10.2 pts | ||
| 3 months | -63.0% | -1.2% | −61.9 pts | ||
| Year to date | -58.7% | +12.3% | −71.0 pts | ||
| 1 year | -60.3% | +12.4% | −72.8 pts | ||
| 3 years | -76.6% | +78.8% | −155.4 pts | -38.4% | +21.4% |
| 5 years | -90.3% | +75.2% | −165.5 pts | -37.3% | +11.9% |
| 10 years | -76.5% | +311.1% | −387.6 pts | -13.5% | +15.2% |
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Press releases
Releases Dyadic International filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Results
- News
- Update
- Update
- Results
About Dyadic International
Biological Products, (No Diagnostic Substances)
Dyadic International, Inc., operating as Dyadic Applied BioSolutions, is a biotechnology company that develops, manufactures, and commercializes animal-free recombinant proteins and enzymes. The company utilizes its proprietary microbial expression platforms, Dapibus and C1, to produce precision-engineered proteins for research, diagnostics, cell culture media, functional food ingredients, and industrial biotechnology. Its offerings include cell culture reagents such as albumin, transferrin, and fibroblast growth factor, diagnostics products like DNase I, and food ingredients including caseins and lactoferrin. Dyadic serves customers and partners across the life sciences, food and nutrition, bio-industrial, and pharmaceutical sectors through direct product sales, distribution partnerships, manufacturing collaborations, and technology licensing agreements.
Company profile, executives and historyDyadic International stock: common questions
What is Dyadic International's stock price?
DYAI closed at $0.39 on Nov 11, 2026, up 6.01% on the day. Over the past 52 weeks it traded between $0.33 and $1.60.
What is Dyadic International's market cap?
Dyadic International was worth $14.14M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is DYAI's P/E ratio?
Dyadic International lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.23), so it has no meaningful P/E ratio.
How much revenue does Dyadic International make?
Dyadic International reported revenue of $3.80M for the twelve months to Jun 30, 2026, down 8.0% from a year earlier.
Does Dyadic International pay a dividend?
No. Dyadic International has not paid a cash dividend over the last twelve months.
When does Dyadic International report earnings next?
Dyadic International is expected to report Q3 FY2026 results on Nov 11, 2026, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has DYAI stock performed over the past year?
Including dividends, DYAI returned -60.3% over the past year, against +12.4% for the S&P 500.
How many DYAI shares are sold short?
0M shares were sold short at the latest FINRA report, 0.32% of the float, or 1.0 days of average trading volume.
Who are Dyadic International's competitors?
Companies most similar to Dyadic International by business, industry and size include ZEOX, MOLN, PLUR, ELOX, ATRA.
See a number that looks wrong?